Denecimig

DB18426InvestigationalProtein Based Therapies

Denecimig: Overview.

Mechanism: Pharmacologically active on Coagulation factor X and Coagulation factor IX
Curator reviewed
Also known as: Immunoglobulin G4 [230-proline,de-449-lysine], anti-(human blood-coagulation factor IX) (human clone 0365-0001-9985 γ4-chain), disulfide with human clone 0365-0001-9985 κ-chain, (228.fwdarw.226′),(231.fwdarw.229′)-bis(disulfide) with anti-(human bl
Code names: NNC0365-3769

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Denecimig, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.